GENE GARRARD OLINGER, JR
Pilots at Sumner Dr, Frederick, MD
License number
Maryland A4199629
Issued Date
Jun 2016
Expiration Date
Jun 2018
Category
Airmen
Type
Authorized Aircraft Instructor
Address
Address
2023 Sumner Dr, Frederick, MD 21702
Professional information
Compositions And Methods For Treatment Of Filovirus-Mediated Diseases
US Patent:
2011002, Feb 3, 2011
Filed:
Feb 22, 2010
Appl. No.:
12/710203
Inventors:
Lisa M. Johansen - Belmont MA, US
Benjamin G. Hoffstrom - Cambridge MA, US
Gene G. Olinger - Frederick MD, US
Andrea R. Stossel - Thurmont MD, US
Benjamin G. Hoffstrom - Cambridge MA, US
Gene G. Olinger - Frederick MD, US
Andrea R. Stossel - Thurmont MD, US
International Classification:
A61K 31/135
US Classification:
514657
Abstract:
The invention features compositions, methods, and kits useful for the treatment of filovirus-mediated diseases, e.g., hemorrhagic fever caused by Ebola virus, in an animal.
Compositions And Methods For Treatment Of Filovirus-Mediated Diseases
US Patent:
2013028, Oct 31, 2013
Filed:
Jun 27, 2013
Appl. No.:
13/928630
Inventors:
Lisa M. JOHANSEN - Belmont MA, US
Benjamin G. HOFFSTROM - Cambridge MA, US
Gene G. OLINGER - Frederick MD, US
Andrea R. STOSSEL - Thurmont MD, US
Benjamin G. HOFFSTROM - Cambridge MA, US
Gene G. OLINGER - Frederick MD, US
Andrea R. STOSSEL - Thurmont MD, US
International Classification:
A61K 31/5415, A61K 31/496
US Classification:
5142255, 51425308
Abstract:
The invention features compositions, methods, and kits useful for the treatment of filovirus-mediated diseases, e.g., hemorrhagic fever caused by Ebola virus, in an animal.
Ebola Peptides And Immunogenic Compositions Containing Same
US Patent:
2003022, Dec 4, 2003
Filed:
Mar 10, 2003
Appl. No.:
10/384976
Inventors:
Mary Hart - Frederick MD, US
Julie Wilson - Birmingham AL, US
Gene Olinger - Frederick MD, US
Michael Bailey - Frederick MD, US
Julie Wilson - Birmingham AL, US
Gene Olinger - Frederick MD, US
Michael Bailey - Frederick MD, US
International Classification:
C12Q001/70, C07H021/04, A61K039/12, C12N007/00, C07K014/005
US Classification:
424/199100, 435/005000, 435/235100, 530/350000, 536/023200
Abstract:
Using CTL epitopes to the Ebola GP, NP, VP24, VP30, VP35 and VP40 virion proteins, a method and composition for use in inducing an immune response which is protective against infection with Ebola virus is described.
Cobalt Hexammine As A Potential Therapeutic Against Hiv And/Or Ebola Virus
US Patent:
2011002, Feb 3, 2011
Filed:
Jul 30, 2010
Appl. No.:
12/847342
Inventors:
Eddie L. Chang - Silver Spring MD, US
Lisa Hensley - Frederick MD, US
Dzung C. Thach - Annandale VA, US
Andy Knight - New Orleans LA, US
Gene Olinger - Frederick MD, US
Lisa Hensley - Frederick MD, US
Dzung C. Thach - Annandale VA, US
Andy Knight - New Orleans LA, US
Gene Olinger - Frederick MD, US
Assignee:
The Government of the US, as represented by the Secretary of the Navy - Washington DC
International Classification:
A61K 33/24, A61P 31/18, A61P 31/14, A61P 31/12, A61J 1/05, A61M 5/00
US Classification:
424646, 604403, 604264, 604272
Abstract:
Hexaamminecobalt(III) chloride, also called Cohex, reduces the extent of viral infection, including difficult to treat infections caused by Ebola virus and HIV. Disclosed are methods for treating a viral infection, comprising administering to a patient a cobalt(III) hexammine compound in an amount effective to reduce an extent of a viral infection. Also disclosed are kits for delivery of a cobalt(III) hexammine compound by injection.